HIV-HCV
Coinfection Top News Articles
|
| |
|
|
|
|
Experimental
CCR5 Antagonist Vicriviroc Appears Safe and
Well Tolerated in HIV/HCV Coinfected
Patients
1-15-2010
|
Liver
Transplants Do Not Impair Immune Response in
HIV/HCV Coinfected Patients
1-15-2010
|
Lower
CD4 Count Predicts Slow HCV Decline and Poor Response
to Pegylated Interferon plus Ribavirin in HIV/HCV
Coinfected People
1-05-2010
|
Black
HIV/HCV Coinfected Patients
Experience Slower HCV Decline and Are Less Likely than
Whites to Respond to Hepatitis C Treatment
1-05-2010
|
Nearly
One-third of HIV/HCV Coinfected
Patients with Normal ALT Have Liver Fibrosis
that Indicates Treatment
12-15-2009
|
Factors
that Influence the Decision of HIV/HCV
Coinfected Patients to Start Treatment for
Hepatitis C
12-15-2009 |
Sustained
Response to Pegylated Interferon plus Ribavirin in HIV/HCV
Coinfected Patients with Advanced Immune Suppression
12-15-2009
|
Meta-analysis
Shows Hepatitis C Virus Coinfection
Does Not Lead to HIV Disease Progression
11-17-2009
|
Study
Looks at Factors Affecting Survival of HIV/HCV
Coinfected Liver Transplant Recipients
11-13-2009
|
Rapid
Liver Fibrosis Progression and Successful Treatment of
Acute Infection Suggest Benefits of Routine HCV
Screening for HIV Positive Men
11-10-2009
|
New
HCV Infection
Is Occurring among HIV Positive
U.S. Men, ACTG Analysis Shows
11-7-2009
|
Meta-analysis
Shows Hepatitis C Virus Coinfection
Does Not Lead to HIV Disease Progression
11-7-2009
|
HIV-HCV
Coinfected Patients Are More Likely to Experience
HCV Relapse after Completing Treatment, Usually within
12 Weeks
10-30-2009
|
Cochrane
Review of Pegylated Interferon Plus Ribavirin for Hepatitis
C Treatment in People with HIV
10-27-2009
|
HCV
Viral Load Decline during the First 24 Hours of Interferon-based
Therapy Predicts Long-term Outcomes in HIV-HCV
Coinfected Patients
9-18-2009 |
HIV
Positive People May Respond Poorly to Pegylated
Interferon without Ribavirin for Acute Hepatitis
C
9-15-2009 |
HIV/HCV
Coinfected Women in WIHS Study Not at Greater
Risk of Atherosclerosis
9-11-2009 |
Early
Treatment of Acute HIV and Hepatitis C in People
with Simultaneous Coinfection
9-11-2009 |
Growing
Epidemic of Hepatitis C among Gay and Bisexual
Men in Amsterdam
9-01-2009 |
HIV-HCV
Coinfected Individuals in Italy Are Likely
to also Have Occult Hepatitis B Virus
8-21-2009 |
Survey
Reveals Wide Variation in Clinicians' Approaches to Hepatitis
C Treatment in People with HIV
8-21-2009 |
Sustained
Response to Pegylated Interferon
plus Ribavirin Reduces Liver Complications
and Mortality in HIV-HCV Coinfected
Patients
8-18-2009 |
Does
Psychiatric Co-morbidity Predict Treatment Response in
HIV-HCV Coinfected Patients
with a History of Injection Drug Use?
8-14-2009 |
HIV
Positive People with Hepatitis C Virus Coinfection
Are More Likely to Develop AIDS-defining Illnesses
8-11-2009 |
HIV-HCV
Coinfected Patients Treated with NRTI-Sparing Antiretroviral
Regimens Respond Better to Pegylated Interferon plus Ribavirin
8-11-2009 |
Poor
Outcomes with Ribavirin Pre-treatment and Double-dose
Pegylated Interferon in HIV-HCV
Coinfected Patients
8-7-2009 |
Insulin
Resistance Is Not a Significant Predictor of Sustained
Response to Interferon-based Therapy in HIV-HCV
Coinfected Patients
7-07-2009 |
HIV
Infection Itself Does Not Affect the Risk of Developing
Diabetes, but HIV-HCV Coinfection
Plays a Role
7-07-2009 |
HIV
Medical Association Supports Public
Health Plan Option
6-23-2009 |
HAART
May Reduce Liver Inflammation in HIV-HCV
Coinfected Patients with High CD4 Cell Count
6-19-2009 |
Predictors
of Sustained Treatment Response in HIV-HCV
Coinfected Patients Receiving Routine Care
6-16-2009
|
Does
HIV-HCV Coinfection
Increase the Risk of Liver Disease Progression and Worsen
Clinical Outcomes?
6-9-2009
|
HIV-HCV
Coinfected and HCV Monoinfected Patients with
Genotype 2-3 Respond Equally Well to 24 Weeks of Pegylated
Interferon plus Ribavirin
6-5-2009 |
HIV-HCV
Coinfected Individuals and Those with HIV-HBV-HCV
Triple Infection Have a Higher Risk of Death in the HAART
Era
6-2-2009
|
Does
HIV-HCV Coinfection
Increase the Risk of Liver Disease Progression and Worsen
Clinical Outcomes?
6-9-2009 |
HIV-HCV
Coinfected and HCV Monoinfected Patients with
Genotype 2-3 Respond Equally Well to 24 Weeks of Pegylated
Interferon plus Ribavirin
6-5-2009 |
Antiviral
Agents with Activity against Both HIV
and Hepatitis C Virus
6-2-2009 |
|
|
Sustained
Response to Interferon-based
Therapy for Hepatitis C Reduces Risk of Liver
Toxicity Due to Antiretroviral
Drugs for HIV
5-29-2009
|
HIV
Negative Individuals with Hepatitis C and HIV-HCV
Coinfected Patients Have Similar Hepatocellular
Carcinoma Outcomes
5-29-2009
|
Hepatitis
C Virus Coinfection May Be a Risk Factor for Atherosclerosis
in HIV Positive Individuals
5/22/09 |
Acute
Hepatitis C Affects Neurocognitive
Functioning in People with HIV
5/22/09 |
Studies
Find No Evidence of Hepatitis C Virus Relapse or Significant
Fibrosis after Spontaneous Clearance in HIV-HCV
Coinfected Individuals
5/19/09
|
Viral
Hepatitis Coinfection Is Linked to Bone Loss in HIV
Positive Women but Not Men
4/17/09
|
HIV
Positive and Negative Individuals with Acute or Early
Chronic Hepatitis C Respond Well to 24 Weeks of Pegylated
Interferon plus Ribavirin
4/10/09
|
Successful
Antiretroviral Therapy May Increase T-cell Response against
Hepatitis C Virus in HIV-HCV
Coinfected Individuals
4/10/09
|
Studies
Shed More Light on Acute Hepatitis
C among HIV Positive Men in the U.S. and Europe
4/07/09
|
Outcomes
of Liver Transplantation in HIV Positive Recipients Coinfected
with Hepatitis B or C
3/24/09
|
Virological
Response Can Help Determine Optimal Duration of Pegylated
interferon/ribavirin Treatment for HIV-HCV
Coinfected Patients
3/20/09 |
Daniel
Fierer Speaks at HIV-HCV Coinfection
Forum in San Francisco Tuesday Night
3/17/09 |
Studies
Look at Liver Fibrosis in HIV-HCV
and HIV-HBV Coinfected People
3/13/09 |
Studies
from Europe and the U.S. Provide Further Information on
Sexual Transmission of Hepatitis
C Virus among HIV Positive Men
3/10/09 |
Without
HAART, HIV Infection Accelerates Hepatitis C Disease Progression
in Coinfected Individuals
3/06/09 |
Uninterrupted
HAART, more than Hepatitis C Treatment, Predicts Survival
in HIV-HCV Coinfected Patients
3/06/09 |
High
HCV Viral Load Is Associated with an Increased Risk of
Death in HIV-HCV Coinfected Individuals
3/03/09 |
Adequate
Ribavirin Level Promotes Sustained Response to Interferon-based
Therapy for HIV-HCV Coinfected
Patients
2/20/09 |
HIV-HCV
Coinfected Women May Experience More Pegylated
Interferon and Ribavirin Side Effects than Men
2/20/09 |
HIV-HCV
Coinfected Patients Experience Longer Hospitalization,
More Emergency Visits, and Greater Disability than People
with HIV Alone
2/17/09 |
Despite
Infrequent "Blips," Tenofovir
(Viread) Provides Good Hepatitis B Virus Suppression
HIV-HBV Coinfected Individuals
2/17/09 |
Complete
Early Response to Pegylated Interferon/ribavirin Predicts
Sustained Response in HIV-HCV
Coinfected Patients: SLAM-C
2/17/09 |
Human
Genetic Variation Associated with Good T-cell Response
Predicts Successful Treatment in HIV-HCV
Coinfected Patients
2/17/09 |
Does
Early Treatment for HIV Prevent Liver Fibrosis in HIV-HCV
Coinfected Patients?
1/30/2009 |
Pegylated
Interferon Alfa-2a (Pegasys) and Alfa-2b (PegIntron)
Work Equally Well in HIV-HCV Coinfected Patients
1/23/2009
|
Maternal
Neutralizing Antibodies Do Not Prevent Mother-to-Child
HCV Transmission from HIV-HCV
Coinfected Mothers
1/20/2009 |
GBV-C,
SEN Virus, and Occult HBV Infection in HIV-HCV
Coinfected Patients
1/10/2009 |
HIV
Positive People May Be Slow to Develop HCV Antibodies
during Acute Infection, HCV
RNA Test More Accurate
1/05/2009 |
